Tandem Diabetes Care Appoints Raj Sodhi to Board of Directors
December 14 2020 - 4:05PM
Business Wire
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin
delivery and diabetes technology company, today announced the
appointment of Rajwant (Raj) Singh Sodhi as an independent member
of its board of directors effective January 1, 2021. He will
succeed Edward Cahill, who has served as a board member for the
Company since May 2009. Mr. Sodhi is president of the software as a
service (SaaS) business at ResMed (NYSE: RMD, ASX: RMD). He brings
to the Tandem board more than 25 years of digital strategy
experience, SaaS commercialization and operations across multiple
industries including healthcare, financial services, and
telecom.
“We are pleased to welcome Raj to our Board of Directors at this
important next stage of Tandem’s evolution,” said John Sheridan,
president and chief executive officer. “Raj’s deep experience in
driving innovation through software technologies will be invaluable
to Tandem as we grow our business and advance our ecosystem of
data-driven products and services in support of improving the lives
of people with diabetes.”
“I’d like to express our deep appreciation to Ed for his
contributions as a member of our Board over the past 11 years,”
said Kim Blickenstaff, chairman of the board. “He has provided
valuable insight and support at every stage of our company as we
transformed from a small start-up to a leader in insulin therapy
management.”
Mr. Sodhi joined ResMed in 2012 through the acquisition of
Umbian Inc., of which he was co-founder and president. Since that
time, Mr. Sodhi has served in several positions at ResMed including
President of Healthcare Informatics where he led the creation of
ResMed’s portfolio of digital solutions that connects more than 12
million patients globally to ResMed’s ecosystem of cloud-connected
medical devices and digital health technologies that have
transformed care for people with sleep apnea, COPD, and other
chronic diseases. Since 2016, Mr. Sodhi has led a series of
healthcare IT acquisitions focused on software platforms serving
providers outside of the hospital and building a new segment of
growth for ResMed that represents 12 percent of ResMed’s global
revenues and enables providers across the United States to serve
more than 100M+ patients and residents.
Before ResMed and Umbian, Mr. Sodhi worked in the financial
services industry, designing, developing and managing SaaS
solutions. He was senior vice president of business development and
chief technology officer for Skipjack Financial Services, and
co-founder and chief technology officer of TransActive Ecommerce
Solutions. Mr. Sodhi holds a Master of Business Administration and
a Bachelor of Science in mathematics and statistics from Dalhousie
University in Halifax, Nova Scotia.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical
device company dedicated to improving the lives of people with
diabetes through relentless innovation and revolutionary customer
experience. The Company takes an innovative, user-centric approach
to the design, development and commercialization of products for
people with diabetes who use insulin. Tandem’s flagship product,
the t:slim X2™ insulin pump, is capable of remote software updates
using a personal computer and features integrated continuous
glucose monitoring. Tandem is based in San Diego, California.
Tandem Diabetes Care is a registered trademark and t:slim X2 is
a trademark of Tandem Diabetes Care, Inc.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use
#tslimX2, and $TNDM. Follow Tandem Diabetes Care on Facebook at
www.facebook.com/TandemDiabetes. Follow Tandem Diabetes Care on
LinkedIn at https://www.linkedin.com/company/tandemdiabetes.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201214005694/en/
Media Contact: Steve Sabicer 714-907-6264
ssabicer@thesabicergroup.com
Investor Contact: Susan Morrison 858-366-6900 x7005
IR@tandemdiabetes.com
Tandem Diabetes Care (NASDAQ:TNDM)
Historical Stock Chart
From Apr 2024 to May 2024
Tandem Diabetes Care (NASDAQ:TNDM)
Historical Stock Chart
From May 2023 to May 2024